Home » AstraZeneca Establishes First Russian Biobank

AstraZeneca Establishes First Russian Biobank

January 17, 2013

AstraZeneca is expanding its biotechnology operations in Russia, through the establishment of the country’s first biobank and a clinical research center in St. Petersburg, Russia.
Bio-IT World

05Aug
Pharmaceutical Quality Risk Management: Navigating the Intersection Between Regulatory Requirements & Risk Management
10Aug
Is Biosimilars Regulation Taking a Major Turn?: The Latest Must-Know Developments, Including BsUFA III
12Aug
On-Site Inspections: They’re Back — But When, Where and How
28Sep
4th Annual WCG MCC Clinical Trial Risk & Performance Management Collaborative vSummit
18Oct
MAGI's Clinical Research vConference — Fall 2021

AstraZeneca Establishes First Russian Biobank

Upcoming Events

Pharmaceutical Quality Risk Management: Navigating the Intersection Between Regulatory Requirements & Risk Management

Is Biosimilars Regulation Taking a Major Turn?: The Latest Must-Know Developments, Including BsUFA III

On-Site Inspections: They’re Back — But When, Where and How

4th Annual WCG MCC Clinical Trial Risk & Performance Management Collaborative vSummit

MAGI's Clinical Research vConference — Fall 2021

Featured Products

Biological Risk Evaluation and Management for Medical Devices

GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

AstraZeneca’s Once-a-Week Diabetes Drug Approved for Children

PathogenDx Gains CE Mark for COVID-19 Test

Shionogi Begins Human Trials of First Once-A-Day Pill for COVID-19 Patients

Becton Dickinson’s Vacutainer Gets EUA for COVID-19

The Revised ICH E8: A Guide to New Clinical Trial Requirements